Drug Type Small molecule drug |
Synonyms Buprenorphine/meloxicam |
Mechanism COX-2 inhibitors(Cyclooxygenase-2 inhibitors), κ opioid receptor antagonists(Kappa opioid receptor antagonists), μ opioid receptor agonists(Mu opioid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Bridge Therapeutics, Inc.Startup |
Active Organization Bridge Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H42ClNO4 |
InChIKeyUAIXRPCCYXNJMQ-RZIPZOSSSA-N |
CAS Registry53152-21-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | US | Bridge Therapeutics, Inc.Startup | - |